Parallel trade

Article originally published in PLC Cross-border Life Sciences Handbook, 2007/08

Apart from patent disputes linked to generic entry, perhaps no issue has spawned more litigation in the European pharmaceutical sector than parallel trade. At the root of the problem are price differences among member states for pharmaceutical products which are
Continue Reading Parallel Trade in Pharmaceuticals and EC Competition Law

Originally published as Covington Life Sciences Alert on June 1st, 2005

May a dominant pharmaceutical company refuse to supply in full the orders it receives from a wholesaler in an EU country in order to limit parallel trade in its products in the European Union? This was the question put
Continue Reading Parallel Trade in Pharmaceutical Products in Europe: The European Court of Justice’s Ruling in Syfait v. GSK